Jeff Albers

Track

Insider profile

Currently holds positions in Dianthus Therapeutics Inc and Blueprint Medicines Corp

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Dianthus Therapeutics Inc July 1, 2017 -
President, Chief Executive Officer, Director Blueprint Medicines Corp July 1, 2014 -
Jeff Albers's trades of Spyre Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
160.62
Quantity 58,100 -17.1%
Value US$1,922,202
Transaction date
Planned sale
Price
432.69
Quantity 61,287 +39.9%
Value US$2,712,825
Transaction date
Planned sale
Price
436.03
Quantity 53,807 +20.2%
Value US$3,055,570
Transaction date
Proposed sale
Price
103.42
Quantity 18,000
Value US$1,861,560
Transaction date
Proposed sale
Price
103.42
Quantity 5,000
Value US$517,100
Transaction date
Proposed sale
Price
66.62
Quantity 5,000
Value US$333,100
Transaction date
Proposed sale
Price
43.13
Quantity 6,349
Value US$273,832
Transaction date
Proposed sale
Price
101.14
Quantity 5,000
Value US$505,686
Transaction date
Proposed sale
Price
109.39
Quantity 10,000
Value US$1,093,929
Transaction date
Proposed sale
Price
109.79
Quantity 5,161
Value US$566,627
Transaction date
Proposed sale
Price
102.28
Quantity 5,000
Value US$511,398
Transaction date
Proposed sale
Price
89.78
Quantity 15,000
Value US$1,346,633
Transaction date
Proposed sale
Price
102.00
Quantity 5,000
Value US$510,000
Transaction date
Proposed sale
Price
33.70
Quantity 7,000
Value US$235,900
Transaction date
Proposed sale
Price
85.57
Quantity 19,702
Value US$1,685,911
Transaction date
Proposed sale
Price
47.78
Quantity 5,000
Value US$238,900
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-10 2026-08-07
PlS Planned sale
58,100 -17.1%
160.62
US$1,922,202 		58,100 -17.1% 160.62 US$1,922,202
2026-08-10 2026-08-07
PlS Planned sale
61,287 +39.9%
432.69
US$2,712,825 		61,287 +39.9% 432.69 US$2,712,825
2026-08-10 2026-08-07
PlS Planned sale
53,807 +20.2%
436.03
US$3,055,570 		53,807 +20.2% 436.03 US$3,055,570
2026-08-07 2026-08-07
PrS Proposed sale
18,000
103.42
US$1,861,560 		18,000 103.42 US$1,861,560
2026-08-07 2026-08-07
PrS Proposed sale
5,000
103.42
US$517,100 		5,000 103.42 US$517,100
2025-12-08 2025-12-08
PrS Proposed sale
5,000
66.62
US$333,100 		5,000 66.62 US$333,100
2025-12-08 2025-12-08
PlS Planned sale
2,252 -100.0%
90.30
US$203,363 		2,252 -100.0% 90.30 US$203,363
2025-12-08 2025-12-08
PlS Planned sale
2,748 -55.0%
89.32
US$245,460 		2,748 -55.0% 89.32 US$245,460
2025-10-14 2025-10-13
PrS Proposed sale
5,000
57.21
US$286,050 		5,000 57.21 US$286,050
2025-10-14 2025-10-13
PlS Planned sale
5,000 -100.0%
59.19
US$295,949 		5,000 -100.0% 59.19 US$295,949
2025-06-03 2025-06-03
PrS Proposed sale
6,349
43.13
US$273,832 		6,349 43.13 US$273,832
2025-06-03 2025-06-03
PlS Planned sale
6,349 -100.0%
49.00
US$311,101 		6,349 -100.0% 49.00 US$311,101
2025-05-29 2025-05-27
PlS Planned sale
650 -0.4%
101.93
US$66,254 		650 -0.4% 101.93 US$66,254
2025-05-29 2025-05-27
PlS Planned sale
4,350 -2.9%
101.02
US$439,437 		4,350 -2.9% 101.02 US$439,437
2025-05-27 2025-05-27
PrS Proposed sale
5,000
101.14
US$505,686 		5,000 101.14 US$505,686
2025-03-14 2025-03-12
PlS Planned sale
1,800 -1.2%
88.37
US$159,066 		1,800 -1.2% 88.37 US$159,066
2025-03-14 2025-03-12
PlS Planned sale
5,700 -3.6%
87.62
US$499,434 		5,700 -3.6% 87.62 US$499,434
2025-03-17 2025-03-05
S Sale
5,766 -3.8%
88.80
US$512,021 		5,766 -3.8% 88.80 US$512,021
2025-01-23 2025-01-21
PlS Planned sale
200 -0.1%
110.61
US$22,122 		200 -0.1% 110.61 US$22,122
2025-01-23 2025-01-21
PlS Planned sale
7,400 -4.6%
109.92
US$813,408 		7,400 -4.6% 109.92 US$813,408
2025-01-23 2025-01-21
PlS Planned sale
7,561 -4.5%
109.11
US$824,981 		7,561 -4.5% 109.11 US$824,981
2025-01-21 2025-01-21
PrS Proposed sale
10,000
109.39
US$1,093,929 		10,000 109.39 US$1,093,929
2025-01-21 2025-01-21
PrS Proposed sale
5,161
109.79
US$566,627 		5,161 109.79 US$566,627
2025-01-15 2025-01-13
PlS Planned sale
5,000 -3.1%
102.28
US$511,400 		5,000 -3.1% 102.28 US$511,400
2025-01-14 2025-01-13
PrS Proposed sale
5,000
102.28
US$511,398 		5,000 102.28 US$511,398
2024-12-20 2024-12-19
PlS Planned sale
2,100 -1.3%
91.96
US$193,116 		2,100 -1.3% 91.96 US$193,116
2024-12-20 2024-12-19
PlS Planned sale
3,800 -2.3%
91.15
US$346,370 		3,800 -2.3% 91.15 US$346,370
2024-12-20 2024-12-19
PlS Planned sale
5,180 -3.1%
89.01
US$461,072 		5,180 -3.1% 89.01 US$461,072
2024-12-20 2024-12-19
PlS Planned sale
3,920 -2.3%
88.28
US$346,058 		3,920 -2.3% 88.28 US$346,058
2024-12-19 2024-12-19
PrS Proposed sale
15,000
89.78
US$1,346,633 		15,000 89.78 US$1,346,633
2024-11-12 2024-11-07
PrS Proposed sale
5,000
102.00
US$510,000 		5,000 102.00 US$510,000
2024-11-12 2024-11-07
PlS Planned sale
5,000 -3.1%
102.00
US$510,000 		5,000 -3.1% 102.00 US$510,000
2024-11-07 2024-11-07
PrS Proposed sale
5,000
102.00
US$510,000 		5,000 102.00 US$510,000
2024-11-08 2024-11-06
PlS Planned sale
6,700 -19.7%
36.76
US$246,313 		6,700 -19.7% 36.76 US$246,313
2024-10-28 2024-10-25
PlS Planned sale
300 -0.9%
36.43
US$10,929 		300 -0.9% 36.43 US$10,929
2024-10-25 2024-10-25
PrS Proposed sale
7,000
33.70
US$235,900 		7,000 33.70 US$235,900
2024-09-11 2024-09-09
PlS Planned sale
7,734 -4.7%
85.12
US$658,318 		7,734 -4.7% 85.12 US$658,318
2024-09-11 2024-09-09
PlS Planned sale
11,968 -6.8%
85.86
US$1,027,572 		11,968 -6.8% 85.86 US$1,027,572
2024-09-09 2024-09-09
PrS Proposed sale
19,702
85.57
US$1,685,911 		19,702 85.57 US$1,685,911
2024-08-26 2024-08-26
PrS Proposed sale
5,000
47.78
US$238,900 		5,000 47.78 US$238,900
2024-08-26 2024-08-26
PlS Planned sale
5,000 -100.0%
49.10
US$245,508 		5,000 -100.0% 49.10 US$245,508
2024-03-22 2024-03-20
PlS Planned sale
1,367 -0.8%
89.12
US$121,827 		1,367 -0.8% 89.12 US$121,827
2024-03-22 2024-03-20
PlS Planned sale
6,285 -3.4%
88.60
US$556,851 		6,285 -3.4% 88.60 US$556,851
2024-03-22 2024-03-20
PlS Planned sale
8,440 -4.4%
87.26
US$736,474 		8,440 -4.4% 87.26 US$736,474
2024-03-22 2024-03-20
PlS Planned sale
6,251 -3.2%
86.46
US$540,461 		6,251 -3.2% 86.46 US$540,461